15% OFF $150+· CodeFALL15
Ends October 15Shop now
Lot certificates published
Discreet shipping

Molecular mechanism

GHRH receptor

A class B G-protein-coupled receptor expressed on anterior pituitary somatotrophs. Synthetic growth hormone-releasing factor analogs are characterized by their activity at this receptor.

Type: receptorPublished: 2026-09-04Literature/identifier verification: 2026-08-23
GHRHRGrowth hormone-releasing hormone receptor

01

Neutral molecular overview

A class B G-protein-coupled receptor expressed on anterior pituitary somatotrophs. Synthetic growth hormone-releasing factor analogs are characterized by their activity at this receptor.

02

Target identifiers

Gene symbols
GHRHR

03

Related compounds

04

Related mechanisms

05

Verified bibliography

  1. Tesamorelin, a human growth hormone releasing factor analogue.

    Wang Y, Tomlinson B

    Expert opinion on investigational drugs · 2009-03 · Review

    current
  2. Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects.

    González-Sales M, Barrière O, Tremblay PO, Nekka F, Mamputu JC, Boudreault S, Tanguay M

    Clinical pharmacokinetics · 2015-03 · Journal Article

    current
  3. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog.

    Jetté L, Léger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, Paradis V, van Wyk P, Pham K, Bridon DP

    Endocrinology · 2005-04-07 · Journal Article

    current
  4. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.

    Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA

    The Journal of clinical endocrinology and metabolism · 2005-12-13 · Journal Article

    current
  5. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.

    Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R

    American journal of physiology. Endocrinology and metabolism · 2006-07-05 · Journal Article

    current
  6. Drug evaluation: tesamorelin, a synthetic human growth hormone releasing factor.

    Tomlinson B

    Current opinion in investigational drugs (London, England : 2000) · 2006-10 · Review

    current
  7. Tesamorelin.

    Grunfeld C, Dritselis A, Kirkpatrick P

    Nature reviews. Drug discovery · 2011-02 · News

    current

06

Related glossary terms

07

Related Purely Peptides research articles

No existing Research Article is mapped to this mechanism seed record.